Skip to main content

Table 2 Comparison between CCLs in the studied groups

From: Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level

Chemokines Pg/ml

Control group (n 20)

Group 1 (n 31)

eGFR. ≥ 60

Group 2 (n 50)

eGFR 30–59.9

Group 3 (n 20)

eGFR≤ 29.9

K

P

P1

P2

P3

P4

P5

P6

CCL1

1.95 (195–1.95)

1.95 (1.95–2.41)

1.95 (195–2.2)

2.9 (2.1–4)

15.8

0.001

NS

NS

0.000

NS

0.006

0.003

CCL2

140.26 (61.6–261)

105.4 (101.1–184.7)

140.5 (104. 3-178.5)

121.7 (100. 5-205.2)

0.2

NS

      

CCL3

4.6 (2. 7-6.9)

4.17 (3. 2-5.5)

4.3 (3. 8-5.4)

3.9 (2. 9-5)

1.8

NS

      

CCL4

25.8 (17. 3-55.4)

80.7 (22. 5-109.6)

63 (42. 8-93.5)

59.2 (31. 6-86.9)

11.9

0.008

0.028

0.000

0.014

NS

NS

NS

CCL5

6332 (3018–13,060)

5446 (3197–7945)

4189 (3225–6344)

2930 (1066–4812)

7.7

NS

      

CCL8

20.53 (16. 17-26.19)

22.4 (18. 7-27.1)

26.3 (21. 3-31.2)

25.1 (18. 2-30.4)

3.9

NS

      

CCL11

173.1 (25. 6-315.9)

111.8 (79. 4-176.5)

97 (39. 2-168.4)

60.6 (24. 5-88.7)

4.8

NS

      

CCL13

43.96 (30-82)

49.2 (10. 7-69.6)

39.2 (20. 1-61.5)

38.4 (10. 7-94.4)

0.4

NS

      

CCL15

2065 (1357–2798)

2725 (2208–3898)

3152 (2502–4246)

5769 (3738–7418)

20.6

0.000

0.011

0.003

0.000

NS

0.10

0.007

CCL17

21.34 (14.54–32.81)

21.7 (16. 1-29.6)

21.4 (17. 2-31.2)

37.7 (19. 9-51.4)

4.6

NS

      

CCL21

29.03 (193. 4-392.6)

183.7 (100. 5-262.3)

182.7 (77. 4-262.3)

208.3 (77. 2-700.2)

2.1

NS

      

CCL24

356.4 (176. 4-452.9)

262.7 (203. 9-347.9)

246.9 (188. 4-377.1)

328.3 (209. 7-487.9)

1.7

NS

      

CCL26

48.83 (48. 8-49.8)

48.8 (48. 8-48.8)

48.8 (48. 8-48.8)

48.8 (48. 8-48.8)

6.8

NS

      

CCL27

564.9 (444. 1-643.2)

682.7 (580. 8-844.5)

695.7 (625. 4-888.9)

1078 (930. 1-1339)

26.9

0.000

0.029

0.003

0.000

NS

0.000

0.001

CXCL5

419.3 (258. 1-574.5)

354.8 (255. 7-493.2)

402.2 (329. 5-518.2)

290.8 (159. 7-534.5)

2.3

NS

      

CXCL8

3.99 (1. 7-7.8)

12.8 (8. 8-20.3)

11.7 (9. 7-15.2)

13.8 (7. 9-16.2)

18.9

0.000

0.000

0.000

0.000

NS

NS

NS

CXCL10

392.9 (281. 1-500.7)

930.7 (542. 5-1947)

1057 (749–1521)

739.3 (396. 2-1408)

19.4

0.000

0.000

0.000

0.003

NS

NS

NS

CXCL12

2027 (1446–3055)

1753 (1278–3102)

1603 (1136–2318)

2406 (990. 2-4122)

2.5

NS

      

CXCL13

21.9 (14. 14-36.11)

31.9 (18. 2-82)

36.6 (27. 8-57.4)

37.2 (27. 8-77.5)

8.2

NS

      
  1. Levels of all chemokines expressed as median and 95% confidence interval
  2. CCL Chemokine ligand, eGFR Estimated glomerular filtration rate, K Krusklwallis, P1 Control versus Group 1, P2 Control versus Group 2, P3 Control versus Group 3, P4 group 1 versus Group 2, P5 Group 1 versus group 3, P6 Group 2 versus Group 3, NS Non significant